Ligand Pharmaceuticals Incorporated (NASDAQ:LGND)’s Basic Consolidated EPS Came In At $13.0018

0

The annual basic consolidated EPS for Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) posted annual basic consolidated EPS of $13.0018 for the year period ended2015-12-31. But basic consolidated EPS for the quarter period ended 2015-12-31 came in at $13.0018.

What About EPS from continuing operations

Ligand Pharmaceuticals Incorporated (NASDAQ:LGND)’s EPS from continuing operations for the annual period ended 2015-12-31 came in at 13. On quarterly basis, EPS from continuing operations stood at $13 for the three-month period ended 2015-12-31.

EPS contribution from parent

Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) received of $13.0018 EPS boost from the parent company for the annual period ended 2015-12-31. For the quarter period ended 2015-12-31, the company received EPS boost of $13.0018 from its parent company.

What About Basic net EPS

The company’s basic net EPS for the annual period ended 2015-12-31 was$13, but for the quarter period ended 2015-12-31 the basic net EPS was $13.

What About Consolidated Diluted EPS?

Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) posted consolidated diluted EPS of $12.121 for the annual period ended 2015-12-31. On the other hand, consolidated diluted EPS for the quarterly period ended 2015-12-31 stood at $12.121.

Basic diluted EPS

The company’s diluted EPS from continuing operation stood at $12.12 for the annual period ended 2015-12-31. On quarter basis, diluted EPS from continuing operations was $12.12 for the three-month period ended 2015-12-31.

Net diluted EPS

Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) posted net diluted EPS of $12.12for the annual period ended 2015-12-31. On the other hand, it posted net diluted EPS of $12.12 for thequarterly period ended 2015-12-31.

What portion of diluted EPS came from parent?

For the annual period ended 2015-12-31, the parent company of Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) contributed diluted EPS of $12.121. The diluted EPS contribution from the parent for the quarter ended 2015-12-31 stood at $12.121.

The company’s net basic EPS for the annual period ended 2015-12-31 was $13 while for the quarter period ended 2015-12-31 it was $13.

Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) had average basic shares outstanding of 19.79 for the annual period ended 2015-12-31 and 19.79 for the quarter period ended 2015-12-31.The number of diluted shares outstanding was 21.228 for the annual period ended 2015-12-31 and 21.228 for the quarter ended 2015-12-31.

1 Chart Pattern Every Investor Should Know

This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...

Click Here to See This Now.

(Visited 15 times, 1 visits today)